Previous close | 13.30 |
Open | 13.61 |
Bid | 13.22 x 100 |
Ask | 13.38 x 100 |
Day's range | 13.25 - 13.76 |
52-week range | 8.69 - 24.13 |
Volume | |
Avg. volume | 334,895 |
Market cap | 478.724M |
Beta (5Y monthly) | 1.09 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
UroGen Pharma ( NASDAQ:URGN ) First Quarter 2024 Results Key Financial Results Revenue: US$18.8m (up 9.2% from 1Q...
Insight into UroGen Pharma's First Quarter Financial Performance and Strategic Highlights
We think intelligent long term investing is the way to go. But along the way some stocks are going to perform badly...